Faithful to our Mission and Vision, at Stendhal we are in constant search for growth in the following strategic lines:
Geographical expansion in order to have full marketing throughout Latin America: the first step in this direction is to be established in the Chilean market, as well as cover important markets in Brazil and Argentina through strategic alliances with companies already established in those countries that share our philosophy.
Expansion into our therapeutic areas, both in the diagnostic, as well as therapeutic area, always focused on specialty medicine, a segment of the market where we can guarantee success through highly trained and motivated teams, strategies of ethical and scientifically solid promotional strategies, attractive and innovative continuous medical education programs, and support programs for patients that give an added value to the products we market.
Long term agreements based on the definition of common objectives, clear financial reports, adding value to alliances to increase benefits for all and open communication. All based on the element of trust.
Participation in Clinical Development: based on solid finances of our companies and the attractiveness of our project, Stendhal looks to participate with financial and/or logistic resources in projects related to the clinical development of products that are compatible with the strategy set forth here, particularly those products that have concluded phase II trials with the exchange of the marketing rights in our territory.
If you believe you have a product or service that may be of our interest or are interested in knowing more about us, please contact our New Business Unit.
Dr. Gerardo Sánchez Mejorada Fernández
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
